Disparities Seen in Older Adults' Access to Rehab After Hospitalization for TBI
By Lori Solomon HealthDay Reporter
TUESDAY, March 18, 2025 -- Disparities exist in access to rehabilitation following community discharge for traumatic brain injury (TBI) in older adults based on contextual-level social determinants of health (SDoH), according to a study published online in the March/April issue of the Journal of Head Trauma Rehabilitation.
Chinedu Onwudebe, from the University of Texas Medical Branch at Galveston, and colleagues examined the association between contextual SDoH and receipt of first outpatient or home health (HH) rehabilitation visit after hospital discharge (2014 through 2018) among 19,117 older adult Medicare fee-for-service beneficiaries (aged 66 years and older) with TBI in Texas.
The researchers found that patients living in areas with higher median household incomes (hazard ratio [HR], 0.92) and higher unemployment rates (HR, 0.98) had a decreased likelihood of having an HH visit upon return to community, while those with higher uninsured rates (HR, 0.78) and in rural areas (HR, 0.83) had a decreased likelihood of having an outpatient visit. There was an increased likelihood of having an HH visit with Food Environment Index (HR, 1.08). A higher percentage with severe housing problems (HR, 1.34) increased the likelihood of an outpatient visit. Contextual-level SDoH was associated with a decreased likelihood of an outpatient visit but an increased likelihood of an HH visit, when they were treated as competing events. Overall, more than a third of the older adults received no outpatient rehabilitation or HH care.
"The varying utilization of HH versus outpatient rehabilitation indicates that structural determinants of health inequities, such as policies and practices (e.g., dictating care plans), intermediate determinants, such as the built, natural, and sociocultural environment (e.g., access to food, housing), as well as intrapersonal determinants, such as health literacy and care preferences, may exacerbate the identified differences in access to care," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-19 06:00
Read more

- U.S. Ends Funding for Thousands of Global Health Programs
- Robert F. Kennedy Jr. Downplays Measles Vaccine as Cases Surge
- Breastfeeding Improves Heart Health In Children
- Remibrutinib Beneficial for Urticaria After H1-Antihistamine Treatment
- FDA Approves Arbli (losartan potassium) Oral Suspension as the First Ready-to-Use Oral Liquid Losartan in the U.S.
- Sanofi Adopts FDA-Selected Flu Strains to Ensure Readiness for the 2025-26 Flu Season
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions